BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kahremany S, Hofmann L, Gruzman A, Dinkova-Kostova AT, Cohen G. NRF2 in dermatological disorders: Pharmacological activation for protection against cutaneous photodamage and photodermatosis. Free Radic Biol Med 2022;188:262-76. [PMID: 35753587 DOI: 10.1016/j.freeradbiomed.2022.06.238] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
Number Citing Articles
1 Cuadrado A, Dinkova-Kostova AT, Mann GE. Introduction to Special Issue on "Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases". Free Radic Biol Med 2023;195:258-60. [PMID: 36586454 DOI: 10.1016/j.freeradbiomed.2022.12.100] [Reference Citation Analysis]
2 Cohen D, Portugal‐cohen M, Oron M, Frusic‐zlotkin M, Soroka Y, Ma'or Z, Amar D, Kohen R. Cutaneous Nrf2‐Keap1 pathway modulation by environmental factors: The Dead Sea area as a test case. BioFactors 2022. [DOI: 10.1002/biof.1926] [Reference Citation Analysis]
3 Steinhoff M, Alam M, Ahmad A, Uddin S, Buddenkotte J. Targeting oncogenic transcription factors in skin malignancies: An update on cancer stemness and therapeutic outcomes. Semin Cancer Biol 2022;87:98-116. [PMID: 36372325 DOI: 10.1016/j.semcancer.2022.11.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Panieri E, Telkoparan‐akillilar P, Saso L. NRF2 , a crucial modulator of skin cells protection against vitiligo, psoriasis, and cancer. BioFactors 2022. [DOI: 10.1002/biof.1912] [Reference Citation Analysis]
5 Rasheed M, Butt DMG, Izhar Q, Rasheed M. Personality Construct Among Patients With Substance Use Disorder: An Explanatory Study In Pakistan. IJIST 2022;4:42-49. [DOI: 10.33411/ijist/2022040613] [Reference Citation Analysis]